Background/Purpose: Despite effective vaccine programs, tetanus is occasionally observed in adults. We reviewed clinical presentation data for adult patients with tetanus in the postvaccine era in Taiwan. Methods: We retrospectively reviewed the medical records of all adult patients (age >18 years) discharged from Chang-Gung Memorial Hospital at Lin-Ko (CGMHLK) after treatment for tetanus between January 1996 and July 2005. Data regarding demographic characteristics, clinical manifestation, treatment, and outcome were collected. To assess the features for different age groups, patients were divided into those aged !65 years and those aged <65 years. To identify risk factors for respiratory failure, the patients were classified as those with and without respiratory failure. Results: Twenty-three patients with tetanus, 11 (48%) women and 12 (52%) men, were included in the study. The average age was 57 AE 18 years (range 18e84 years). Eighteen (78%) patients had a history of acute injury. The average incubation period was 8 AE 5 days. The most common clinical presentation at onset was trismus (78%). Thirteen (57%) patients developed respiratory failure and underwent endotracheal intubation. The most common complication was pneumonia (30%). All the patients survived and recovered. Age !65 years was significantly associated with trismus, dysphagia, dysarthria, and pneumonia. Generalized tetanus subtype and pneumonia were significant risk factors for respiratory failure. Conclusion: This study revealed several characteristics of adult tetanus cases in the postvaccine era in Taiwan. Further serological studies and improved tetanus vaccinations may
be needed to ensure better protection, especially for high-risk populations. The exceptionally good prognosis for our patients confirms that appropriate treatment, including wound care, early diagnosis, proper medication, and prevention of complications, is essential in managing this traditional curable disease. Copyright ª 2011, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
Tetanus is a toxin-mediated disease caused by Clostridium tetani, an anaerobic Gram-positive bacillus. Penetrating injury can result in inoculation of the bacterial spores, which are normally present in the guts of mammals and in the soil. The toxin tetanospasmin blocks the release of gaminobutyric acid by inhibitory interneurons and spreads via retrograde axonal transport and trans-synaptic transmission. Tetanospasmin causes tetanus by blocking inhibitory pathways, especially of the motor and autonomic nervous systems. After the incubation period, the patients present with tonic contraction of the skeletal muscles, intermittent painful muscle spasms, and sympathetic overactivity. The diagnosis is usually clinical and treatment is mainly supportive.
Tetanus is a preventable disease. Its incidence has been declining worldwide since the implementation of immunization programs. However, it continues to be an important cause of morbidity and mortality, especially in developing countries. In developed countries, an emerging problem is the high risk of infection in the elderly. In Taiwan, an immunization program has been in place since 1954. There were 1004 cases reported in 1956, when the incidence reached a peak and then gradually decreased. Since 1981, fewer than 20 cases have been reported annually. The incidence was approximately 0.07/100,000 population in recent years. 1 Although rare, cases of adult tetanus continue to occur. Therefore, we conducted a retrospective study to investigate the demographic features, clinical presentations, complications, treatment, and outcome for adult tetanus cases reported between 1996 and 2005 in the post-vaccine era in Taiwan.
Materials and method
We conducted a retrospective review of adult patients aged >18 years discharged from Chang-Gung Memorial Hospital, Lin-Kou (CGMHLK) after treatment for tetanus between January 1996 and July 2005. The CGMHLK is a medical center located in north Taiwan, with more than 3000 inpatient beds. Tetanus was diagnosed on the basis of clinical findings by experienced neurologists, and the diagnosis remained unchanged throughout the hospital stay and subsequent follow-ups. Patients with an uncertain diagnosis were excluded from the study. Data regarding demographic features, presence of concomitant diseases, wound site, incubation period, clinical manifestations, hospital course, complications, medication administered, and outcome were collected. The study protocol was reviewed and approved by the institutional review board of Chang-Gung Memory Hospital.
Higher tetanus incidence and poor immunity are observed in older individuals, so the 23 patients were divided into two groups aged !65 years and <65 years. The groups were compared to analyze differences in clinical characteristics. A severe clinical presentation involves respiratory failure. Therefore, the patients were also divided into groups with and without respiratory failure. The clinical features of these two groups were analyzed to identify possible risk factors for respiratory failure.
The data were analyzed using Statistical Package for the Social Sciences version 15 
Results

Patient characteristics
Twenty-three patients, 11 (48%) women and 12 (52%) men, were included in the study. The mean age was 57 AE 18 years (AE standard deviation). Age data for all patients are presented in Fig. 1 . Among these patients, four (17%) had a history of diabetes mellitus (DM). Other concomitant diseases observed were hypertension (13%), heart disease (9%), chronic obstructive pulmonary disease (4%), chronic kidney disease (4%), and cancer (4%). Regarding occupation, there were three (13%) farmers, two housewives (9%), one carpenter (4%), one cleaner (4%), and one porter (4%). Fifteen patients did not report their occupation. The immune status of the patients was not known, except for one patient who reported that he had not received a tetanus immunization in the previous 10 years.
As summarized in Table 1 , 18 (78%) patients had a history of acute skin injury; the other five (22%) had no injury history. Among these 18 patients, nine (50%) had wounds on the lower limbs, eight (44%) on the upper limbs, three (17%) on the head, and one (6%) on the neck. Three of these patients presented with multiple wounds: two had experienced a fall and one was involved in a fight. One patient had undergone excision of nasal polyps 1 day prior to the onset of symptoms, while another had no history of acute injury but was a drug abuser.
Hospital course and complications
The average incubation period was 8 AE 5 days (range 0e60 days). The clinical presentations at onset are summarized in Table 1 . Trismus was the most common initial presentation, and 19 (89%) of the 23 patients developed generalized tetanus. The clinical types included local and cephalic tetanus, each of which was observed in two (9%) patients. Thirteen (57%) patients developed respiratory failure, with a mean ventilator dependency duration of 16 AE 10 days (range 2e37 days). Fifteen patients were admitted to the intensive care unit (ICU). The average ICU stay was 17 AE 11 days. The average hospitalization duration was 25 AE 15 days (range 3e58 days). Common complications included pneumonia (30%), rhabdomyolysis (13%), upper gastrointestinal bleeding (9%), acute myocardial infarction (9%), acute renal failure (4%), secondary wound infection (4%), and transient cardiac arrest (4%).
Treatment and outcome
Antibiotic treatment was administered to all patients: 19 (83%) were treated with parenteral penicillin and four (17%) with metronidazole. Eighteen (78%) were treated with antitoxin. Eleven (48%) patients received injections of tetanus vaccine during hospitalization. Four (17%) patients underwent wound debridement. Twenty (87%) patients were treated with intravenous benzodiazepine to control muscle spasm. Other antispasmodic agents used were a non-depolarizing muscle relaxant (four patients) and baclofen (four patients). All the patients recovered and were discharged without sequelae. Table 2 compares the clinical features for the patient age groups !65 years and <65 years. Differences between the groups in trismus presentation at onset, dysphagia/dysarthria, and pneumonia complications were significant. Trismus (p Z 0.046) and dysphagia/dysarthria [p Z 0.036, odds ratio (OR) Z 9.000, 95% confidence interval (CI) Z 1.285e63.025] were more common in patients aged ! 65 years, and these patients were more susceptible to pneumonia (p Z 0.019, OR Z 18.00, 95% CI Z 1.632e 198.508). Table 3 shows a comparison between patients with and without endotracheal intubation. The two groups differed significantly in tetanus subtype (generalized or focal type) and complications (with or without pneumonia). The patients with generalized tetanus (p Z 0.024) or with pneumonia (p Z 0.007) were more likely to develop respiratory failure. They stayed in the ICU (p < 0.001) and hospital (p Z 0.014) for a significantly longer duration.
Statistical analysis
Discussion
Our data reveal some typical characteristics of tetanus cases. A higher incidence was observed in older persons. Individuals greater than 40 years of age comprised 82% (19/23) of the patients. Trismus and dysphagia were the two most common initial presentations. Most patients subsequently developed generalized tetanus (82%). Acute respiratory failure (57%) and pneumonia (30%) were the most common complications during hospitalization. Farming and gardening work are high-risk activities. Wound locations, incubation period, initial presentations, and complications were similar to those in previous reports for Taiwan. 2, 3 Recent studies in developed countries have revealed that the high incidence of tetanus in elderly diabetics and intravenous drug abusers is a major concern.
4e6 According to a survey conducted in the USA between 1998 and 2000, diabetic patients constituted 12% of the 130 reported cases of tetanus, and intravenous drug abusers accounted for 15%. 4 In our study, four patients (17%) had a history of DM. The average age of these four patients was 62.8 years, which is greater than the mean patient age in the study (57.4 years). With regard to intravenous drug abuse, one patient had a history of amphetamine abuse. This patient did not have a history of acute wound, but it was not known whether he had used unsterilized syringes or needles to inject other drugs.
Several serological investigations to evaluate immunity to tetanus in developed countries revealed that most people, especially the elderly, do not have adequate immunity to tetanus. 7e9 Wu et al reported that tetanus antitoxin levels decrease with age in Taiwan. Individuals aged >60 years all had protective antitoxin in their serum, but might need a booster to increase the level. 10 An immunization program (diphtheria, tetanus, and pertussis vaccine) was launched in 1954 in Taiwan and has been popular since 1959. The vaccine is administered to all infants at 2, 4, and 6 months of age. Booster doses are given at 18 months and in the first year of elementary school. It is likely that individuals born before 1954 have never received any active immunization. A similar situation exists in developing countries where immunization programs are not well established. 11, 12 In our study, a detailed immunization history was not known for most patients. Only one patient reported that he had not received tetanus immunization in the previous 10 years. These findings indicate that inadequate immune protection might be a major reason for (9) tetanus infection. Booster doses of tetanus toxoid vaccine should be considered, especially for populations at high risk of open wound infection, such as elderly patients with DM or intravenous drug abusers, as suggested in previous reports. 4, 7 Our study also suggests that this should apply to workers in higher-risk occupations, such as farmers.
Owing to the higher incidence of tetanus among the elderly and their poor immunity to this disease, early diagnosis and treatment are important for this group of patients. Our study reveals that elderly patients may present with typical symptoms, such as trismus and dysphagia, more frequently than younger patients. Although the initial differential diagnosis might be confusing, tetanus should always be considered in elderly patients presenting with acute onset of trismus and dysphagia. Survival depends on rapid treatment with antitoxin, high-dose sedatives, muscle relaxants, and adequate supportive care. Specific therapy includes intramuscular administration of tetanus immunoglobulin to neutralize circulating toxin before it binds to neuronal cell membranes. 13 Early prevention of aspiration and administration of antibiotics for pneumonia might reduce the incidence of complications and the cost of treatment.
Mortality usually results from respiratory failure, cardiovascular collapse, or associated autonomic instability. 3, 14 Our results revealed that respiratory failure was significantly associated with generalized tetanus and pneumonia. Respiratory failure also results in prolonged ICU stays. Early endotracheal intubation and even tracheostomy were required in high-risk patients to reduce morbidity and mortality. Early tracheostomy may shorten the ICU stay. According to previous studies in other countries, the mortality rate for tetanus varies from 11% to 70%. 4,15e17 A previous study conducted in Taiwan revealed a mortality rate of 28.6% between 1980 and 1990. 3 It is surprising that there were no fatal cases in our series. The advanced supportive care provided for our patients might have contributed to this exceptionally good outcome. In summary, this study revealed several characteristics of adult tetanus cases in the post-vaccine era in Taiwan. Although a public immunization program has been in place for decades, tetanus still remains a major threat. Further serological investigations and improved vaccination may be needed for better protection, especially for high-risk populations. The exceptionally good prognosis for our patients confirms that appropriate treatment, including wound care, early diagnosis, proper medication, and prevention of complications, is essential in managing this traditional curable disease.
